Cargando…

Pathogenicity of SARS‐CoV‐2 Omicron

Detalles Bibliográficos
Autores principales:	Chu, Hin, Yuen, Kwok‐Yung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092483/ https://www.ncbi.nlm.nih.gov/pubmed/35543251 http://dx.doi.org/10.1002/ctm2.880

Ejemplares similares

Virological features and pathogenicity of SARS-CoV-2 Omicron BA.2
por: Chan, Jasper Fuk-Woo, et al.
Publicado: (2022)

Pathogenicity of SARS-CoV-2 Omicron BA.1.1 in hamsters
por: Chan, Jasper Fuk-Woo, et al.
Publicado: (2022)

Antibody evasion properties of SARS-CoV-2 Omicron sublineages
por: Iketani, Sho, et al.
Publicado: (2022)

The mysterious origins of the Omicron variant of SARS-CoV-2
por: Du, Pei, et al.
Publicado: (2022)

Why is the SARS-CoV-2 Omicron variant milder?
por: Xia, Bingqing, et al.
Publicado: (2022)

Is the Omicron variant of SARS-CoV-2 coming to an end?
por: Zhao, Yingjie, et al.
Publicado: (2022)

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
por: Xia, Shuai, et al.
Publicado: (2022)

Altered host protease determinants for SARS-CoV-2 Omicron
por: Chan, Jasper Fuk-Woo, et al.
Publicado: (2023)

Role of Omicron variant of SARS-CoV-2 in children in Germany
por: Bittmann, Stefan
Publicado: (2022)

SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant
por: Berkhout, Ben, et al.
Publicado: (2022)

Omicron variant of SARS-CoV-2 – A new kid on the block
por: Husain, Uneza, et al.
Publicado: (2022)

The omicron variant of SARS‐CoV‐2: Understanding the known and living with unknowns
por: Ingraham, Nicholas E., et al.
Publicado: (2021)

Renaming the SARS‐CoV‐2 Omicron sublineages as SARS‐CoV‐3 is contrary to nomenclature standards based on evolutionary and serological evidence
por: Qi, Zhongtian, et al.
Publicado: (2022)

The viral fitness and intrinsic pathogenicity of dominant SARS-CoV-2 Omicron sublineages BA.1, BA.2, and BA.5
por: Shuai, Huiping, et al.
Publicado: (2023)

In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron
por: Hu, Ye-Fan, et al.
Publicado: (2022)

SARS‐CoV‐2 Omicron variant: Why global communities should take it seriously?
por: Rahmani, Shayan, et al.
Publicado: (2022)

Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2
por: Hu, Bingjie, et al.
Publicado: (2022)

A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 Omicron variant
por: Chiu, Man Chun, et al.
Publicado: (2022)

A Commentary on “Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learnt” (Int J Surg 2022;97:106198) Contact-tracing and global vaccine equity: Crucial responses to emergence of the Omicron SARS-CoV-2 variant
por: Rahimi, Farid, et al.
Publicado: (2022)

Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters
por: McMahan, Katherine, et al.
Publicado: (2022)

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
por: Suzuki, Rigel, et al.
Publicado: (2022)

A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
por: Zhou, Biao, et al.
Publicado: (2022)

Intranasal infection by SARS-CoV-2 Omicron variants can induce inflammatory brain damage in newly weaned hamsters
por: Li, Can, et al.
Publicado: (2023)

A lethal mouse model using a mouse-adapted SARS-CoV-2 strain with enhanced binding to mouse ACE2 as an important platform for COVID-19 research
por: Chu, Hin, et al.
Publicado: (2021)

A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants
por: Lam, Joy-Yan, et al.
Publicado: (2022)

The spike receptor-binding motif G496S substitution determines the replication fitness of SARS-CoV-2 Omicron sublineage
por: Liang, Ronghui, et al.
Publicado: (2022)

The Rise of SARS-CoV-2 (COVID-19) Omicron Subvariant Pathogenicity
por: DeGrasse, David C, et al.
Publicado: (2023)

A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters
por: Zhao, Hanjun, et al.
Publicado: (2022)

Enhanced replication of SARS-CoV-2 Omicron BA.2 in human forebrain and midbrain organoids
por: Hou, Yuxin, et al.
Publicado: (2022)

Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer
por: Shuai, Huiping, et al.
Publicado: (2020)

Correction: The Rise of SARS-CoV-2 (COVID-19) Omicron Subvariant Pathogenicity
por: DeGrasse, David C, et al.
Publicado: (2023)

Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5
por: Imbiakha, Brian, et al.
Publicado: (2023)

Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB
por: Wang, Yi, et al.
Publicado: (2023)

Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants
por: Zhao, Hanjun, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 in Hong Kong returnees – Authors' reply
por: To, Kelvin Kai-Wang, et al.
Publicado: (2020)

Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction
por: Lau, Siu-Ying, et al.
Publicado: (2020)

SARS-CoV-2 Omicron variant shedding during respiratory activities
por: Tan, Kai Sen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gjdh55h0t0t7769v6opssqbe5s